Patents by Inventor Ryan C. Clark

Ryan C. Clark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pre-connected analyte sensors
    Patent number: 11943876
    Abstract: Pre-connected analyte sensors are provided. A pre-connected analyte sensor includes a sensor carrier attached to an analyte sensor. The sensor carrier includes a substrate configured for mechanical coupling of the sensor to testing, calibration, or wearable equipment. The sensor carrier also includes conductive contacts for electrically coupling sensor electrodes to the testing, calibration, or wearable equipment.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: March 26, 2024
    Assignee: DexCom, Inc.
    Inventors: Jason Halac, John Charles Barry, Becky L. Clark, Chris W. Dring, John Michael Gray, Kris Elliot Higley, Jeff Jackson, David A. Keller, Ted Tang Lee, Jason Mitchell, Kenneth Pirondini, David Rego, Ryan Everett Schoonmaker, Peter C. Simpson, Craig Thomas Gadd, Kyle Thomas Stewart, John Stanley Hayes
  • TREX1 INHIBITORS AND USES THEREOF
    Publication number: 20230234943
    Abstract: Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds for inhibiting three prime repair exonuclease 1 (“TREX1”).
    Type: Application
    Filed: June 25, 2021
    Publication date: July 27, 2023
    Inventors: Thomas Walter DUBENSKY, JR., Ryan C. CLARK, Justin ERNST, Garrick K. PACKARD, Brett BUSCH, Joe Fred NAGAMIZO, Biswajit KALITA, Athisayamani Jeyaraj DURAISWAMY
  • Sulfide alkyl compounds for HBV treatment
    Patent number: 10710959
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: July 14, 2020
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Austin Chen, Yalda Bravo, Nicholas Stock, Bijan Pedram, Jason Jacintho, Ryan C. Clark
  • Pyridyl reverse sulfonamides for HBV treatment
    Patent number: 10428041
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: October 1, 2019
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho
  • Heteroaryl compounds as IRAK inhibitors and uses thereof
    Patent number: 10392375
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: August 27, 2019
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-Lebrun, Ruoxi Lan, Austin Chen, Ryan C. Clark
  • SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
    Publication number: 20190202780
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: December 28, 2018
    Publication date: July 4, 2019
    Inventors: Austin Chen, Yalda Bravo, Nicholas Stock, Bijan Pedram, Jason Jacintho, Ryan C. Clark
  • Pyridyl Reverse Sulfonamides For HBV Treatment
    Publication number: 20190152940
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: November 14, 2018
    Publication date: May 23, 2019
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho
  • Sulfide alkyl compounds for HBV treatment
    Patent number: 10196351
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: February 5, 2019
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Austin Chen, Yalda Bravo, Nicholas Stock, Bijan Pedram, Jason Jacintho, Ryan C. Clark
  • Pyridyl reverse sulfonamides for HBV treatment
    Patent number: 10160742
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: December 25, 2018
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho
  • Heteroaryl compounds as IRAK inhibitors and uses thereof
    Patent number: 10059701
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: August 28, 2018
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-Lebrun, Ruoxi Lan, Austin Chen, Ryan C. Clark
  • HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
    Publication number: 20180237426
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Application
    Filed: April 23, 2018
    Publication date: August 23, 2018
    Inventors: Catherine JORAND-LEBRUN, Ruoxi LAN, Austin CHEN, Ryan C. Clark
  • HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
    Publication number: 20180237413
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Application
    Filed: April 17, 2018
    Publication date: August 23, 2018
    Inventors: Catherine JORAND-LEBRUN, Ruoxi LAN, Austin CHEN, Ryan C. CLARK
  • Heteroaryl compounds as IRAK inhibitors and uses thereof
    Patent number: 9969710
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: May 15, 2018
    Assignee: Merck Patent GmbH
    Inventors: Catherine Jorand-Lebrun, Ruoxi Lan, Austin Chen, Ryan C. Clark
  • Pyridyl Reverse Sulfonamides For HBV Treatment
    Publication number: 20180051000
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: August 14, 2017
    Publication date: February 22, 2018
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho
  • SULFIDE ALKYL COMPOUNDS FOR HBV TREATMENT
    Publication number: 20170298014
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: January 26, 2017
    Publication date: October 19, 2017
    Inventors: Austin Chen, Yalda Bravo, Nicholas Stock, Bijan Pedram, Jason Jacintho, Ryan C. Clark
  • Pyridyl reverse sulfonamides for HBV treatment
    Patent number: 9765050
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: September 19, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho
  • HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
    Publication number: 20170081307
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 23, 2017
    Inventors: Catherine JORAND-LEBRUN, Ruoxi LAN, Austin CHEN, Ryan C. CLARK
  • HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
    Publication number: 20170081317
    Abstract: The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.
    Type: Application
    Filed: September 16, 2016
    Publication date: March 23, 2017
    Inventors: Catherine JORAND-LEBRUN, Ruoxi LAN, Austin CHEN, Ryan C. Clark
  • Sulfide alkyl compounds for HBV treatment
    Patent number: 9597332
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: March 21, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: Austin Chen, Yalda Bravo, Nicholas Stock, Bijan Pedram, Jason Jacintho, Ryan C. Clark
  • PYRIDYL REVERSE SULFONAMIDES FOR HBV TREATMENT
    Publication number: 20160185748
    Abstract: The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
    Type: Application
    Filed: December 2, 2015
    Publication date: June 30, 2016
    Inventors: Ryan C. Clark, Yen Truong, Nicholas Stock, Jason Jacintho